Matt Wolf has been lead trial and appellate counsel in some of the most significant cases brought by and against global life sciences, technology, and consumer goods companies. His professional activities focus on patent, trade secret, licensing, antitrust, and business tort issues.
Matt has been named both a Winning Litigator and Trailblazer by The National Law Journal. He is Chambers (Nationwide) ranked for both IP/Patent Litigation and Intellectual Property, where he has been described as “wickedly smart, very intuitive and terrific in front of a jury” and someone whose “oral advocacy skills are some of the best in the industry.”
He also is top ranked by IAM's Patent Litigation 1000: The World's Leading Patent Litigators, which has noted that he is a "trial supremo;" a "smart guy who knows how to frame the best case," with "tremendous trial skills and a superb ability to think on his feet," and "his cross-examination skills are some of the best." Additionally, he was named a “Client Service All-Star” by BTI Consulting Group. Prior to attending the University of Virginia School of Law, he was World University Debate Champion in 1990.
Experience
- Hologic v. Minerva. As lead trial, appellate, and Supreme Court counsel in patent litigation, secured complete plaintiff and counter-claim defense jury verdict for Hologic, affirmance on appeal, and U.S. Supreme Court upholding of assignor estoppel doctrine. The SCOTUS decision has important implications for patent assignments, employee mobility, and due diligence of corporate transactions.
- Boston Scientific v. Cook Group. Secured a US$158 million jury verdict and a finding of willful infringement as to all asserted patent claims in a suit between competitors in the endoscopy space.
- In re: Mallinckrodt PLC et al. Obtained complete defense verdict in bet-the-company trial, defeating antitrust and civil RICO claims against Mallinckrodt’s leading pharmaceutical, Acthar.
- Amgen v. Sanofi/Regeneron. Successfully invalidated Amgen's patents in jury trial, and subsequently secured affirmance by the Federal Circuit, preserving Sanofi and Regeneron's ability to continue to market its life-saving cholesterol-reducing drug Praluent.
- Hologic v. Fujifilm. Secured a complete win and limited exclusion order in the ITC in investigation of a four patent infringement complaint involving mammography imaging technology.
- Boston Scientific v. Edwards Lifesciences Corp. Obtained jury verdict for Boston Scientific worth US$100 million+ in a patent litigation matter involving transcatheter aortic valves, while also obtaining a complete defense verdict on asserted patent counterclaims.
- Heraeus v. Esschem/Zimmer Biomet. In asserting and defending claims of trade secret misappropriation of orthopedic product technology in the ITC and related district court and 3rd Cir. proceedings, secured complete defense victories and established misappropriation of trade secrets by opposing party.
- BioMerieux v. Hologic/Grifols. Secured a complete jury verdict in defending against a US$100 million patent claim involving HIV-1 detection technology.
- Drug-Coated Stent Wars. In a series of multibillion dollar, multijurisdictional disputes over market leading drug-coated stents, secured total victory for Boston Scientific: (1) JNJ/Wyeth v. Boston Scientific—in case related to drug carriers, invalidated all four patents-in-suit; (2) JNJ/Wyeth v. Boston Scientific—in case involving anti-proliferative drug, invalidated both patents-in-suit; and (3) JNJ v. Boston Scientific—in case involving stent architecture, secured non-infringement judgment.
- Jang v. Boston Scientific. Obtained jury verdict defeating license breach and infringement claims for US$200 million in medical device dispute.
- RGIS v. WIS. In litigation between primary competitors in retail audit space, secured invalidation of all hardware and software claims in district court and CBM proceedings.
- Hologic v. IZI. Obtained infringement verdict and subsequent permanent injunction in suit involving accessories for mammography units.
- Enzo v. GE/Amersham. Summary judgment in a decade-long biotech patent and licensing dispute.
- Inflow v. Boston Scientific Corp. Won complete defense victory against an infringement claim for US$105 million involving medical device architecture patents.
- Freedom Wireless, Inc. v. Verizon Wireless. Represented only victorious defendant in multi-defendant suit involving patents on telecommunications systems and equipment.
- Boston Scientific v. Cook/Guidant. Secured permanent injunction valued at US$5 billion precluding early entry into drug eluting stent market.
- Boston Scientific v. Medtronic. Won judgment in excess of US$160 million and secured injunction against future infringing sales of catheter systems.
- Judicial Comment. Hon T. John Ward (ED Tex.) to the jury in Medtronic v. Boston Scientific (opposing counsel McKool Smith): "You've had an unusual experience in my nine years on the bench. I have never seen a case better tried by either side. So, the lawyers are to be complimented for the way they conducted themselves."
- Judicial Comment. Hon. Ronald M. Whyte (ND Cal.) to parties in Hologic v. SenoRx (opposing counsel Williams & Connolly): "I've tried a number of patent cases and this was a real pleasure. I thought this was the most professionally handled case from both sides that I've seen and it sure made it a lot easier for me, and I appreciate it."
Perspectives
June 11, 2024
BTI Consulting Group Names Three Arnold & Porter Attorneys 2024 'BTI Client Service All-Stars'
June 3, 2024
Managing IP Recognizes 21 Arnold & Porter Lawyers as IP Stars; Fishman Named to “Top 250 Women in IP” List
April 26, 2024
Managing IP Americas Awards 2024 Recognizes Arnold & Porter IP and Life Sciences Transactions Capabilities
February 15, 2024
Chambers Global 2024 Ranks 35 Arnold & Porter Lawyers, 31 Practice Areas
More
Recognition
BTI Consulting Group
Client Service All-Stars: Commercial Litigation and Intellectual Property (Washington, D.C.) (2024)
Chambers USA
Intellectual Property — USA - Nationwide (2024)
Intellectual Property: Litigation — Washington, D.C. (2011-2024)
Life Sciences: IP/Patent Litigation — Nationwide (2023-2024)
Intellectual Property: Litigation — Washington, D.C. (2011-2024)
Life Sciences: IP/Patent Litigation — Nationwide (2023-2024)
Chambers Global
Life Sciences: IP/Patent Litigation — USA (2023-2024)
Intellectual Property: Patent — USA (2021-2023)
Intellectual Property: Patent — USA (2021-2023)
More
Credentials
Education
- J.D., University of Virginia School of Law, 1994
- B.A., Political Science, Yale University, 1990
Admissions
- District of Columbia
- Maryland
- U.S. Court of Appeals for the Federal Circuit
- U.S. Court of Appeals for the First Circuit
- U.S. Court of Appeals for the Fourth Circuit
- U.S. District Court, District of Maryland
- U.S. District Court, Eastern District of Texas
- Supreme Court of the United States